Anticoagulants, Antiplatelets, and Thrombolytics
During the past decade, remarkable progress has been made in the development of new drugs to treat thrombotic and cardiovascular diseases, the number one cause of mortality worldwide. In Anticoagulants, Antiplatelets, and Thrombolytics, leading experts with established records of discovery and inven...
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Totowa, NJ
Humana Press
2004, 2004
|
| Edition: | 1st ed. 2004 |
| Series: | Methods in Molecular Medicine
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer Protocols Archive 1981-2004 - Collection details see MPG.ReNa |
Table of Contents:
- Highlights of Latest Advances in Antithrombotics
- Antiplatelet, Anticoagulant, and Thrombolytic Drug Interactions
- Evaluation of Platelet Antagonists in In Vitro Flow Models of Thrombosis
- Heparin and Low Molecular Weight Heparin in Thrombosis, Cancer, and Inflammatory Diseases
- Are Low Molecular Weight Heparins the Same?
- Antithrombotic Drugs for the Treatment of Heparin-Induced Thrombocytopenia
- Laboratory Methods for Heparin-Induced Thrombocytopenia
- Factor Xa Inhibitors
- Tissue Factor/VIIa in Thrombosis and Cancer
- Tissue Factor Pathway Inhibitor in Thrombosis and Beyond
- Cell Adhesion Molecules
- Development and Applications of Animal Models of Thrombosis
- A Survey of Venous Thrombosis Models
- Arixtra® (Fondaparinux Sodium)
- Oral Thrombin Inhibitor Ximelagatran
- Pharmacogenomics and Coagulation Disorders
- Guidelines for Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism